Study guide
Tissue Reactions, Stochastic Risk and Justification
NMTCB CT
Track your progress as you read
Finished sections get a check mark.
1 CT System Hardware & X-Ray Generation
X-Ray Tube Design and Focal Spots Tube Heat Loading, Bearings and Cooling Beam Filtration and Collimation Scanner Generations and Source/Detector Geometry Detector Technology & Data Acquisition Systems (DAS)
2 Gantry Mechanics & Ancillary Systems
Gantry Architecture, Clearance and Centering Slip Rings, Couch Motion and Load Safety Power Injector Hardware and Safety DICOM, Worklists and Image Archiving
3 Data Acquisition & Scanning Geometries
Axial vs. Helical Scanning & Pitch Mechanics Localizer/Scout Scans & Isocenter Alignment Beam Geometry, Slice Collimation & Data Sampling
4 Mathematical Reconstruction & Image Processing
Projection Data, Image Matrices and Voxel Sampling Filtered Back Projection and Reconstruction Kernels Iterative Reconstruction & AI-Powered Algorithms Hounsfield Unit Scale, Linear Attenuation & Windowing (WW/WL)
5 3D Visualization & Advanced Post-Processing
Multiplanar Reformation (MPR) & Curved Planar Reformation (CPR) Volume Rendering, Maximum/Minimum Intensity Projections & Virtual Endoscopy
6 Image Quality & Performance Metrics
Spatial Resolution, Modulation Transfer Function & Matrix Parameters MTF and Spatial-Resolution Testing Contrast Resolution, Quantum Noise & Temporal Resolution Interdependence of Image Quality Parameters & Radiation Dose
7 CT Artifacts Identification & Correction
Physics-Based Artifacts: Beam Hardening, Cupping & Partial Volume Averaging Equipment & Patient Artifacts: Ring, Motion, Metal & Windmill Effects
8 Quality Assurance & Routine Testing
Daily Quality Control: Water Calibration, Noise & Field Uniformity Periodic Quality Assurance: ACR Phantom Testing & Geometry Verification
9 Patient Communication, Screening & Preparation
Patient Identification, Clinical Screening & Pregnancy Protocols Informed Consent, Pre-Scan Fasting & Anxiety Management Patient Monitoring, Vital Signs Assessment & ECG Gating Setup
10 Infection Control & Medical Emergency Response
Infection Control, Aseptic Technique & Scanner Disinfection Medical Emergencies in the CT Suite: Vasovagal Reactions, Seizures & Code Protocols
11 Contrast Media Chemistry & Administration
Iodinated Contrast Properties: Osmolality, Viscosity & Molecular Structure Contrast Volume, Flow, Duration and Iodine Delivery Intravenous Access, Catheter Gauges & Power Injection Protocols Bolus Tracking, Test Bolus & Contrast Transit Dynamics
12 Non-Vascular Contrast & Adverse Reactions
Oral, Rectal and Enteral Contrast Intrathecal, Intra-articular and Cavitary Contrast Renal Impairment, CI-AKI Risk & Metformin Management Contrast Reactions: Categorization, Prophylaxis & Emergency Treatment
13 Neuroimaging & Head/Neck CT Protocols
Routine Brain and Trauma CT Technique Stroke, Hemorrhage and Targeted Skull-Base CT Facial Bones, Orbits & High-Resolution Temporal Bones Soft Tissue Neck & Paranasal Sinuses Protocols
14 Thoracic & Cardiovascular CT Protocols
Routine Chest CT: Pulmonary Parenchyma & Mediastinal Anatomy High-Resolution CT (HRCT) for Diffuse Interstitial Lung Disease Pulmonary Embolism & Cardiac CT Protocols
15 Abdominal & Pelvic CT Protocols
Multiphase Liver, Pancreas & Renal CT Protocols Gastrointestinal CT: Enterography, Colonography & Acute Abdomen Pelvic Cross-Sectional Anatomy & Gynecologic/Urologic Pathology
16 Musculoskeletal, Vascular & Interventional CT
Cervical, Thoracic and Lumbosacral Spine CT Extremity, Joint and Orthopedic Hardware CT CT Angiography (CTA): Carotid, Aortic & Peripheral Runoff Protocols CT-Guided Interventions: Biopsy, Abscess Drainage & Procedural Safety
17 Hybrid PET/CT and SPECT/CT Procedures
PET/CT Anatomy, Physiology and Attenuation Correction SPECT/CT Anatomy, Physiology and Attenuation Correction
18 Radiation Biology & Dose Descriptors
Radiation Physics, Cellular Interactions & Biological Risk Models Tissue Reactions, Stochastic Risk and Justification CTDI Measurement and Phantom References CTDI Weighting, Pitch and DLP Calculations Size-Specific Dose Estimates Effective-Dose Estimates and Diagnostic Reference Levels
19 Radiation Protection & Dose Optimization
Technical Dose Reduction: Tube Current Modulation & Pediatric ALARA Pediatric, Body-Habitus and Pregnancy Optimization Personnel Protection, Distance and Shielding Jurisdiction, Dose Limits and Personnel Monitoring
Tissue Reactions, Stochastic Risk and Justification
Key Takeaways Explain This Topic AI
Tissue reactions have endpoint-dependent thresholds and dose-related severity.
Stochastic risk concerns probability rather than increasing disease severity with dose.
Population risk models do not predict one patient's outcome precisely.
Last updated: October 2026
Tissue reactions and stochastic risk
Radiation effects are commonly divided into tissue reactions , historically called deterministic effects, and stochastic effects . Tissue reactions arise when enough cells or tissue function are affected to produce clinically observable injury. They generally have practical dose thresholds, and severity tends to increase as dose rises beyond the relevant range. Stochastic protection models address the probability of outcomes such as cancer, with dose affecting probability rather than determining the severity of an individual cancer.
A threshold is not a switch that produces zero affected people below one exact number and 100% above it. Threshold definitions, individual variability, dose rate, fractionation, tissue and the endpoint all matter. Avoid a table claiming that every tissue reaction appears with certainty as soon as a numerical threshold is crossed.
Distinguish the effect being discussed
- Effect class Dose-response concept
- Tissue reaction Endpoint-dependent threshold; severity can increase with dose
- Stochastic effect Probability-related protection model rather than dose-dependent disease severity
- Individual outcome Not guaranteed from one population coefficient or nominal threshold
- Tissue reactions in CT practice
Routine optimized diagnostic CT is not expected to produce the high local doses associated with most clinically apparent tissue reactions. However, repeated brain perfusion or prolonged image-guided exposure can concentrate dose in a limited region. Skin effects or hair loss have occurred with excessive CT exposure, so acquisition repetition and cumulative local exposure deserve attention.
The eye lens is also relevant. ICRP Publication 118 uses a nominal threshold of approximately 0.5 Gy for lens tissue reactions in its radiation-protection framework. This is not a diagnostic CT dose limit or a guarantee that every exposed person's outcome is known. Reduce direct lens irradiation when the clinical task and safe positioning permit, and distinguish acquired beam exclusion from postacquisition reformation.
A local tissue-dose estimate may require the actual geometry and exposure history. CTDIvol and DLP support monitoring but do not directly equal skin or lens dose. When an unusually prolonged or repeated protocol is identified, inform the responsible team and involve a medical physicist rather than multiplying a generic patient dose by a memorized threshold ratio.
Radiosensitivity and cellular context
Rapidly proliferating and less differentiated cell populations are often relatively radiosensitive. Bone marrow precursors, intestinal crypt cells and developing tissues are useful examples. Mature neurons and muscle generally have different proliferative behavior. The Bergonié–Tribondeau principle is a useful tendency, not an exceptionless law; mature lymphocytes illustrate that a nondividing cell can still be highly radiosensitive.
Age, organ, developmental stage and exposure pattern affect consequences. Children may have greater lifetime radiation-related risk for a comparable examination because of tissue sensitivity and the time available for delayed outcomes. Pregnancy assessment must consider whether the fetus is in the beam and the actual acquisition, not only the patient's age or a generic effective-dose estimate.
Stochastic effects and the protection model
The linear no-threshold (LNT) model assumes that incremental cancer risk is proportional to dose without an operational threshold for protection purposes. At low diagnostic doses, risk estimates have uncertainty and do not predict that a particular patient will develop cancer. An assumed small increase in population probability is different from a proven outcome for an individual.
Do not claim that stochastic disease severity rises in direct proportion to dose. In the model, dose changes the chance of an outcome; the resulting cancer's behavior depends on many clinical factors. Heritable effects are included in protection frameworks, but that does not mean they have been demonstrated in every human population exposed to diagnostic imaging.
Latency is variable. Radiation-associated malignancy may occur years later, with patterns depending on disease and population. One exact delay does not establish that a tumor was caused by a past scan. Risk communication should acknowledge the clinical benefit and the uncertainty without declaring zero risk or inevitable harm.
Justification and optimization have different jobs
Justification asks whether an examination is appropriate for the patient's clinical need. Optimization asks how to obtain the required information with a reasonable exposure. The lowest possible dose is not necessarily optimal if the result is nondiagnostic and leads to another scan. Conversely, a polished image does not justify unnecessary phases.
Consider a patient whose ordered multiphase protocol includes a phase unrelated to the actual question. The responsible team should review whether that phase is needed. If it is removed appropriately, the patient avoids that acquisition while the required diagnostic information remains. This is a different action from indiscriminately reducing mAs until a subtle lesion can no longer be detected.
Communicate radiation risk usefully
Explain the purpose of the examination, how it may change care and what optimization is being applied. Avoid a universal “number of chest x-rays” equivalence or a precise personal cancer prediction from effective dose. Patients can make a more informed decision when the benefit and the concrete exposure choices are explained together.
A technologist's practical contribution includes correct positioning, adequate coaching, appropriate protocols, avoidance of unnecessary repeats and accurate dose records. These actions are connected to biology because they reduce needless energy deposition without sacrificing the information needed for care. The same protection principles apply when the CT component is part of PET/CT or SPECT/CT, although radiopharmaceutical and CT exposures must be assessed separately.
References: ICRP tissue-reaction report , FDA medical x-ray optimization .